Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, announced today that the Company closed its previously announced private placement with investors including Oracle Investment Management, Jack W. Schuler, Birchview Fund LLC and several Vermillion directors. Total proceeds were $10.5 million, before offering expenses.
from The Medical News http://ift.tt/1tg5rwU
from The Medical News http://ift.tt/1tg5rwU
No comments:
Post a Comment